General Announcement::Clarification relating to S&P Global Rating

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
25-May-2017 19:51:35
Status
New
Announcement Sub Title
Clarification relating to S&P Global Rating
Announcement Reference
SG170525OTHRZLU6
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary and Compliance Officer
Effective Date and Time of the event
25/05/2017 17:00:00
Description (Please provide a detailed description of the event in the box below)
Sub:- Clarification relating to S&P Global Rating

Glenmark would like to clarify that S&P Global Ratings has reaffirmed our credit rating as BB as part of their annual review cycle. In addition, they have affirmed BB issue rating on the senior unsecured notes issued last year. However, they have changed the outlook from Stable to Negative based on their internally defined criteria.
Kindly find enclosed rating research update issued by S&P Global for your reference.

Attachments

SGX_25-05.2017.pdf
Total size =885K